Загрузка...
Bone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myeloma
Skeletal lesions contribute substantially to morbidity and mortality in patients with cancer. The disease manifestation course during metastatic bone disease is driven by tumour cells in the bone marrow, which alter the functions of bone-resorbing (osteoclasts) and bone-forming (osteoblasts) cells,...
Сохранить в:
| Опубликовано в: : | Bonekey Rep |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4606491/ https://ncbi.nlm.nih.gov/pubmed/26512321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2015.113 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|